Latest Form 4 insider transactions

John D Grampa, a Director of Park Ohio Holdings Corp, received 93 shares of common stock on August 14, 2026.

Eyal Talor, Chief Scientific Officer of Cel Sci Corp, received 250,000 shares of common stock on August 14, 2026.

Patricia B Prichep, Chief Financial Officer of Cel Sci Corp, received 225,000 shares of common stock on August 14, 2026.

Geert R Kersten, Chief Executive Officer and a Director of Cel Sci Corp, received 300,000 shares of common stock on August 14, 2026.

Franky Minnifield, a Director of Community Trust Bancorp Inc /Ky/, sold 3,900 shares of common stock on August 14, 2026 for $78.85 per share.

Japan Post Holdings Co., Ltd. reported changes in beneficial ownership of Aflac Inc common stock on August 13, 2026.

Margaret Knight, a Director of Exodus Movement, Inc., sold 135 shares of common stock on August 3, 2026 for $5.11 per share.

Or Offer, Chief Executive Officer of Similarweb Ltd., sold 709,597 shares of common stock on August 13, 2026.

Eran Havshush, a Director of Nayax Ltd., sold 20 shares of common stock on August 13, 2026 for $52.61 per share.

Fulcrum Therapeutics and Slate Medicines are merging in an all-stock transaction, aiming to create a well-capitalized migraine-focused biotech company with a projected cash runway into 2029.

HomeTrust Bancshares, Inc. announced a definitive merger agreement to acquire Blue Ridge Bankshares, Inc. in an all-stock transaction valued at approximately $448.1 million.

HomeTrust Bancshares, Inc. announced a definitive merger agreement to acquire Blue Ridge Bankshares, Inc. in an all-stock transaction valued at approximately $448.1 million.

Fulcrum Therapeutics and Slate Medicines announce a merger agreement, combining forces to advance Slate's migraine therapeutics pipeline, supported by a $245 million financing.

Karni Yarl Andorn, a Director of Camtek Ltd, sold 5,532 shares of common stock on August 13, 2026.

Brian R Balbirnie, Director, CEO, a Director and 10% owner of Issuer Direct Corp, purchased 10,000 shares of common stock on August 14, 2026 for $4.95 per share.

Ryan Bond, a Director of Aclarion, Inc., purchased 21,122 shares of common stock on August 13, 2026 for $2.37 per share.

Wesley T Pollard, a Director of Issuer Direct Corp, purchased 2,000 shares of common stock on August 14, 2026 for $4.99 per share.

William Wesemann, a Director of Aclarion, Inc., purchased 2,150 shares of common stock on August 13, 2026 for $2.34 per share.

David K Neal, a Director of Aclarion, Inc., purchased 7,500 shares of common stock on August 13, 2026 for $2.40 per share.

Brent Ness, Chief Executive Officer and a Director of Aclarion, Inc., purchased 5,234 shares of common stock on August 13, 2026 for $2.31 per share.

Haris Fozan Basit, Chief Strategy Officer of Bitdeer Technologies Group, purchased 25,000 shares of common stock on August 14, 2026 for $8.84 per share.

Shad Good, VP, Sales for North America of IceCure Medical Ltd., received 131,483 shares of common stock on August 14, 2026.

Charles L Wilkins, Head of HSA Bank of Webster Financial Corp, reported multiple transactions in common stock on August 13, 2026.

Olivier Bernhard, Executive Officer and a Director of On Holding AG, purchased 65,000 shares of common stock on August 14, 2026 for $30.67 per share.

Caspar Felix Coppetti, Executive Officer & Co-CEO and a Director of On Holding AG, purchased 65,000 shares of common stock on August 14, 2026 for $30.67 per share.

Marissa Weidner, Chief Corp. Resp. Officer of Webster Financial Corp, reported multiple transactions in common stock on August 13, 2026.

Vikram A. Nafde, Chief Information Officer of Webster Financial Corp, reported multiple transactions in common stock on August 13, 2026.

Jason A. Soto, Chief Credit Officer of Webster Financial Corp, reported multiple transactions in common stock on August 13, 2026.

Jason E. Schugel, Chief Risk Officer of Webster Financial Corp, reported a transaction in 830 shares of common stock on August 13, 2026.

Luis Massiani, President and COO of Webster Financial Corp, reported multiple transactions in common stock on August 13, 2026.